Label (F97ea60b 3e1d 4040 9d97 D9df73851434 03)
Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 70771-1530
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 70771-1530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (F97ea60b 3e1d 4040 9d97 D9df73851434 04)
Dimethyl Fumarate capsules are a medication taken orally twice a day, with each delayed-release hard gelatin capsule containing 120mg of the active ingredient. The capsules need to be stored between 15°C to 30°C and protected from light. The medication should be kept out of reach of children and swallowed whole. The manufacturer of the medication is located in Ahmedabad, India.*
Label (F97ea60b 3e1d 4040 9d97 D9df73851434 05)
This is a medication information for Dimethyl Fumarate. Each delayed-release hard gelatin capsule contains 240g of the medication. The recommended dosage is to take one capsule twice a day. The capsules should be stored between 15°C to 30°C (59°F to 86°F), protected from light, and kept in their original container. This medication is prescription-only and manufactured in Ahmedabad, India. The instructions advise swallowing the capsule whole and keeping all drugs out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
